Delos Wealth Advisors, LLC Eli Lilly & CO Transaction History

Delos Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$592.2 - $792.28 $6,514 - $8,715	11 Added 550.0%	13 $10,000
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $46,741 - $55,102	-89 Reduced 97.8%	2 $1,000
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $592 - $675	2 Added 2.25%	91 $29,000
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $17,132 - $21,291	-73 Reduced 45.06%	89 $25,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $36,425 - $45,204	162 New	162 $45,000

4,011

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $727B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Delos Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Delos Wealth Advisors, LLC with notifications on news.